Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE — In this Healio Video Perspective from the ARVO meeting, Michael H. Goldstein, MD, of Aurion Biotech ...

The corneal edema market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of corneal edema in the US is expected to increase, driven by the launch ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Using hypotonic riboflavin to induce swelling in the cornea can protect patients with keratoconus ...

GDDs significantly increase corneal edema risk compared to trabeculectomy, with a 27.7% incidence versus 13.5% for trabeculectomy. MIGS and Xen stents show lower risks for corneal edema, with ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment practices, persistent corneal edema emerging drugs, market share of ...

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today ...

Hazy vision is a symptom of corneal edema secondary to endothelial dysfunction. (Aurion Biotech Image) Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that ...

Eyeyon Medical Ltd. has won CE mark approval for its flagship product, Endoart, a synthetic implant that replaces the human endothelium, which the body can’t regenerate. Designed to treat chronic ...

The Food and Drug Administration recently approved a new contact lens for the treatment of corneal edema —an eye condition that causes swelling, fluid build up, blurred vision, haziness and scarring.